Showing 1 - 2 of 2 results
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor. It represents an effective therapeutic option for patients with ROS1-, NTRK1-3-, or ALK-rearranged malignancies who have progressed on earlier-generation tyrosine kinase inhibitors...
Status:
Other
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
ANA-12 is a low-molecular weight antagonist of tropomyosin-related kinase B (TrkB), which is the main receptor of neurotrophin brain-derived neurotrophic factor (BDNF). TrkB and BDNF are both the key mediators in the pathophysiology of several mood ...